immunogenicity of ghk-cu antibody formation risk Assessment Biotherapeutics Using an Ex Vivo B Cell Assay Reducing Immunogenicity by Design: Approaches – The tri-peptide GHK-Cu complex ameliorates
Pay in 4 interest-free payments of $7.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

























